Ashwin Sachdeva

Education/Academic qualification

Bachelor of Medicine and Bachelor of Surgery, Newcastle University

Doctor of Philosophy, The impact of mitochondrial alterations on prostate cancer progression, Newcastle University

The Royal College of Surgeons of England

Master of Science, Interdisciplinary Medicine & Engineering, The University of Manchester

Areas of expertise

RD Surgery
Urology
Prostate cancer

Research Beacons, Institutes and Platforms

Cancer
Digital Futures
Manchester Cancer Research Centre

Keywords

Prostate cancer
Clinical trials
Translational research
Cancer metabolism

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

SDG 3 Good Health and Well-being
SDG 4 Quality Education
SDG 9 Industry, Innovation, and Infrastructure
SDG 17 Partnerships for the Goals

Fingerprint

Dive into the research topics where Ashwin Sachdeva is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

49 Article
8 Meeting Abstract
8 Review article
2 Conference contribution
More

Cardiovascular Events and Androgen Receptor Signaling Inhibitors in Advanced Prostate Cancer: A Systematic Review and Meta-Analysis
El-Taji, O., Taktak, S., Jones, C., Brown, M., Clarke, N. & Sachdeva, A., 6 Jun 2024, In: JAMA oncology. 10, 7, p. 874-884 11 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
273 Downloads (Pure)
Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol
Attard, G., Murphy, L., Clarke, N. W., Sachdeva, A., Jones, C., Hoyle, A., Cross, W., Jones, R. J., Parker, C. C., Gillessen, S., Cook, A., Brawley, C., Gilson, C., Rush, H., Abdel-Aty, H., Amos, C. L., Murphy, C., Chowdhury, S., Malik, Z. & Russell, J. M. & 30 others, Parkar, N., Pugh, C., Diaz-Montana, C., Pezaro, C., Grant, W., Saxby, H., Pedley, I., O'Sullivan, J. M., Birtle, A., Gale, J., Srihari, N., Thomas, C., Tanguay, J., Wagstaff, J., Das, P., Gray, E., Alzouebi, M., Parikh, O., Robinson, A., Montazeri, A. H., Wylie, J., Zarkar, A., Cathomas, R., Brown, M. D., Jain, Y., Dearnaley, D. P., Mason, M. D., Gilbert, D., Langley, R. E. & Millman, R., 2 May 2023, In: The Lancet. Oncology. 24, 5, p. 443-456 14 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial
Attard, G., Parry, M., Grist, E., Mendes, L., Dutey-Magni, P., Sachdeva, A., Brawley, C., Murphy, L., Proudfoot, J., Lall, S., Liu, Y., Friedrich, S., Ismail, M., Hoyle, A., Ali, A., Haran, A., Wingate, A., Zakka, L., Wetterskog, D. & Amos, C. & 26 others, Atako, N. B., Wang, V., Rush, H., Jones, R., Leung, H. Y., Cross, W., gillessen, S., Parker, C., Chowdhury, S., Lotan, T., Marafioti, T., Urbanucci, A., Schaeffer, E., Spratt, D. E., Waugh, D. J. J., Powles, T., Berney, D., Sydes, M., Parmar, M., Hamid, A., Feng, F., Sweeney, C., Davicioni, E., Clarke, N., James, N. D. & Brown, L., 8 Feb 2023
Research output: Other contribution
European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update
Brouwer, O. R., Albersen, M., Parnham, A., Protzel, C., Pettaway, C. A., Ayres, B., Antunes-Lopes, T., Barreto, L., Campi, R., Crook, J., Fernández-Pello, S., Greco, I., van der Heijden, M. S., Johnstone, P. A. S., Kailavasan, M., Manzie, K., Marcus, J. D., Necchi, A., Oliveira, P. & Osborne, J. & 9 others, Pagliaro, L. C., Garcia-Perdomo, H. A., Rumble, R. B., Sachdeva, A., Sakalis, V. I., Zapala, Ł., Sánchez Martínez, D. F., Spiess, P. E. & Tagawa, S. T., 7 Mar 2023, (E-pub ahead of print) In: European Urology.
Research output: Contribution to journal › Review article › peer-review
Management of Lymph Node-positive Penile Cancer: A Systematic Review
Sachdeva, A., McGuinness, L., Zapala, Ł., Greco, I., Garcia-Perdomo, H. A., Kailavasan, M., Antunes-Lopes, T., Ayres, B., Barreto, L., Campi, R., Crook, J., Johnstone, P., Kumar, V., Manzie, K., Marcus, J. D., Necchi, A., Oliveira, P., Osborne, J., Pagliaro, L. C. & Protzel, C. & 11 others, Bryan Rumble, R., Sánchez Martínez, D. F., Spiess, P. E., Tagawa, S. T., van der Heijden, M. S., Parnham, A. S., Pettaway, C. A., Albersen, M., Sangar, V. K., Brouwer, O. R. & Sakalis, V. I., 17 May 2023, In: European Urology.
Research output: Contribution to journal › Article › peer-review

Open Access

Prostate Cancer Foundation Young Investigator Award
Sachdeva, A. (Recipient), 2022
Prize: Fellowship awarded competitively
European Urology Impact Award
Sachdeva, A. (Recipient), Mar 2024
Prize: Prize (including medals and awards)
NIHR Impact Prize 2025: The STAMPEDE Trial
James, N. D. (Recipient), Clarke, N. (Recipient), Parmar, M. K. B. (Recipient), Attard, G. (Recipient) & Sachdeva, A. (Recipient), 2025
Prize: Prize (including medals and awards)
The Urology Foundation Research Scholarship Medal
Sachdeva, A. (Recipient), 2015
Prize: Prize (including medals and awards)

Bone Resorptive Agents and Their Appropriate Use and Timing
Sachdeva, A. (Speaker)
2 Jun 2024
Activity: Talk or presentation › Invited talk › Research

Risk of Cardiovascular Side Effects with Newer Hormone Therapies
Sachdeva, A. & Clarke, N.
2/07/24
1 item of Media coverage
Press/Media: Research
Meta-Analysis Evaluates Cardiovascular Risks of AR Inhibitors in Prostate Cancer
Sachdeva, A. & El-Taji, O.
28/06/24
1 item of Media coverage
Press/Media: Research
Prostate Cancer UK: STAMPEDE Winter Innovation Event 2024
Sachdeva, A.
6/03/24
1 Media contribution
Press/Media: Other
European Urology Podcast March 2024: Management of lymph node positive penile cancer
Sachdeva, A.
5/03/24
1 Media contribution
Press/Media: Research

Ashwin Sachdeva, PhD FRCS

Personal profile

Education/Academic qualification

Areas of expertise

Research Beacons, Institutes and Platforms

Keywords

Expertise related to UN Sustainable Development Goals

Fingerprint

Cardiovascular Events and Androgen Receptor Signaling Inhibitors in Advanced Prostate Cancer: A Systematic Review and Meta-Analysis

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol

Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial

European Association of Urology-American Society of Clinical Oncology Collaborative Guideline on Penile Cancer: 2023 Update

Management of Lymph Node-positive Penile Cancer: A Systematic Review

Prostate Cancer Foundation Young Investigator Award

European Urology Impact Award

NIHR Impact Prize 2025: The STAMPEDE Trial

The Urology Foundation Research Scholarship Medal

Bone Resorptive Agents and Their Appropriate Use and Timing

Risk of Cardiovascular Side Effects with Newer Hormone Therapies

Meta-Analysis Evaluates Cardiovascular Risks of AR Inhibitors in Prostate Cancer

Prostate Cancer UK: STAMPEDE Winter Innovation Event 2024

European Urology Podcast March 2024: Management of lymph node positive penile cancer

Ashwin Sachdeva, PhD FRCS

Personal profile

Education/Academic qualification

Areas of expertise

Research Beacons, Institutes and Platforms

Keywords

Expertise related to UN Sustainable Development Goals

Fingerprint

Research output

Prizes

Activities

Press/Media